Methods for treating cancer using anti-wnt2 monoclonal...

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01)

Patent

CA 2566498

This invention relates to methods of inhibiting the growth of cells, in particular cancer cells, that overexpress Wnt2. The methods comprise contacting the cell with an agent that binds to Wnt2 mRNA or Wnt2 protein, interferes with Wnt2 signaling or inhibits binding of the Wnt2 protein to another protein, such as a Frizzled receptor.

L'invention concerne des procédés d'inhibition de la croissance de certaines cellules, en particulier les cellules cancéreuses, qui surexpriment Wnt2. Les procédés consistent à mettre en contact la cellule avec un agent qui se lie à l'ARNm Wnt2 ou à la protéine Wnt2, qui interfère avec la signalisation Wnt2 ou qui inhibe la liaison de la protéine Wnt2 avec une autre protéine, telle que le récepteur Frizzled.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods for treating cancer using anti-wnt2 monoclonal... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for treating cancer using anti-wnt2 monoclonal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating cancer using anti-wnt2 monoclonal... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1415085

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.